Institutional Ownership
Candel Therapeutics Inc
CUSIP 137404109COMCADLQ1 2026
13D / 13G Filings
13
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
109
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
13 filings · latest Jan 21, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.2% | 2.86M | SEC |
| 2 | Jun 30, 2025 | Acorn Bioventures, L.P. | 13G | 5.2% | 2.58M | SEC |
| 3 | May 15, 2025 | Baker Bros. Advisors LP | 13G/A | 5.0% | 2.46M | SEC |
| 4 | Feb 14, 2025 | Northpond Ventures, LP | 13G/A | — | 913.31M | SEC |
| 5 | Feb 14, 2025 | Baker Bros. Advisors LP | 13G | 6.8% | 2.98M | SEC |
| 6 | Feb 7, 2025 | Cvi Investments, Inc. | 13G/A | — | 49 | SEC |
| 7 | Feb 7, 2025 | Fmr LLC | 13G/A | 15.0% | 6.32M | SEC |
| 8 | Feb 7, 2025 | Fmr LLC | 13G | 9.3% | 3.92M | SEC |
| 9 | Dec 17, 2024 | Cvi Investments, Inc. | 13G | 5.6% | 2.35M | SEC |
| 10 | Feb 9, 2023 | Fmr LLC | 13G/A | 2.6% | — | SEC |
3 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Candel Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 10.99M | $53.84M |
| 2 | Rtw Investments, LP | 6.42M | $31.47M |
| 3 | Acorn Capital Advisors, LLC | 3.50M | $17.21M |
| 4 | Blackrock, Inc. | 3.11M | $15.23M |
| 5 | Saturn V Capital Management LP | 2.90M | $14.19M |
| 6 | Portolan Capital Management, LLC | 2.89M | $14.18M |
| 7 | Vestal Point Capital, LP | 1.13M | $5.51M |
| 8 | Millennium Management LLC | 1.06M | $5.19M |
| 9 | Geode Capital Management, LLC | 1.04M | $5.07M |
| 10 | Halter Ferguson Financial Inc. | 904.1K | $4.43M |